Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions (NCT06558825)
Development and Pilot Testing of a Mental Health Clinic-Based PrEP Uptake and Adherence Intervention for Women in Treatment for Trauma-Related Conditions
🩺 Plain-English Summary (8th-Grade Level)
The investigators have previously developed an integrated bio-behavioral intervention to promote PrEP uptake and adherence in cisgender women who are undergoing treatment for trauma-related mental health conditions and who are at a higher risk for HIV. The intervention is delivered within the mental health treatment setting and integrates knowledge, behavioral skills, and motivation to engage in and adhere to PrEP care. The purpose of this study is to assess the preliminary efficacy, feasibility, and acceptability of this intervention. The hypothesis is that, compared to standard treatment, the intervention will be feasible, acceptable, and associated with greater PrEP uptake and adherence.
Who can join: Review the eligibility criteria below.
Location: Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston — Houston, Texas
Age range: 18 Years
🧪 Interventions in This Study
- Integrated Intervention to Promote PrEP Uptake (BEHAVIORAL)
- Standard Treatment Condition (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston — Houston, Texas
📞 Contact the Study Coordinator
Phone: (713) 486-2830
Email: Angela.M.Heads@uth.tmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance Use
- The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project — Columbus, Ohio
- Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples — Ann Arbor, Michigan
- Substance Use Treatment and Its Role in Supporting Social Cognition — Fort Lauderdale, Florida
- Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care) — Torrance, California
- Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders — Ann Arbor, Michigan
- Community Driven Substance Use Recovery for High Opioid Overdose Areas — Bridgeport, Connecticut
Explore by condition: All Substance Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.